Publication Information

{'id': 'https://openalex.org/W1997313140', 'doi': 'https://doi.org/10.1177/0091270009351173', 'title': 'Lack of a Pharmacokinetic Interaction Between Oral Treprostinil and Bosentan in Healthy Adult Volunteers', 'display_name': 'Lack of a Pharmacokinetic Interaction Between Oral Treprostinil and Bosentan in Healthy Adult Volunteers', 'publication_year': 2010, 'publication_date': '2010-02-05', 'ids': {'openalex': 'https://openalex.org/W1997313140', 'doi': 'https://doi.org/10.1177/0091270009351173', 'mag': '1997313140', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/20133511'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1177/0091270009351173', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S146237847', 'display_name': 'The Journal of Clinical Pharmacology', 'issn_l': '0091-2700', 'issn': ['0091-2700', '1552-4604'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320595', 'host_organization_name': 'Wiley', 'host_organization_lineage': ['https://openalex.org/P4310320595'], 'host_organization_lineage_names': ['Wiley'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5029379464', 'display_name': 'S. Karl Gotzkowsky', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210136935', 'display_name': 'United Therapeutics (United States)', 'ror': 'https://ror.org/03wgxjb31', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210136935']}, {'id': 'https://openalex.org/I4210090916', 'display_name': 'Triangle', 'ror': 'https://ror.org/00fhbr831', 'country_code': 'US', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I4210090916']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'S. Karl Gotzkowsky', 'raw_affiliation_strings': ['United Therapeutics Corp., Research Triangle Park, North Carolina'], 'affiliations': [{'raw_affiliation_string': 'United Therapeutics Corp., Research Triangle Park, North Carolina', 'institution_ids': ['https://openalex.org/I4210136935', 'https://openalex.org/I4210090916']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5058093690', 'display_name': 'Jasper Dingemanse', 'orcid': 'https://orcid.org/0000-0002-4083-5817'}, 'institutions': [{'id': 'https://openalex.org/I95056601', 'display_name': 'Actelion (Switzerland)', 'ror': 'https://ror.org/001yedb91', 'country_code': 'CH', 'type': 'company', 'lineage': ['https://openalex.org/I95056601']}], 'countries': ['CH'], 'is_corresponding': False, 'raw_author_name': 'Jasper Dingemanse', 'raw_affiliation_strings': ['Actelion Pharmaceuticals Ltd, Allschwil,Switzerland'], 'affiliations': [{'raw_affiliation_string': 'Actelion Pharmaceuticals Ltd, Allschwil,Switzerland', 'institution_ids': ['https://openalex.org/I95056601']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5003191922', 'display_name': 'Allen A. Lai', 'orcid': None}, 'institutions': [], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Allen Lai', 'raw_affiliation_strings': ['CPKD Solutions, Research Triangle Park, North Carolina'], 'affiliations': [{'raw_affiliation_string': 'CPKD Solutions, Research Triangle Park, North Carolina', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5013897273', 'display_name': 'David Mottola', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210136935', 'display_name': 'United Therapeutics (United States)', 'ror': 'https://ror.org/03wgxjb31', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210136935']}, {'id': 'https://openalex.org/I4210090916', 'display_name': 'Triangle', 'ror': 'https://ror.org/00fhbr831', 'country_code': 'US', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I4210090916']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'David Mottola', 'raw_affiliation_strings': ['United Therapeutics Corp., Research Triangle Park, North Carolina'], 'affiliations': [{'raw_affiliation_string': 'United Therapeutics Corp., Research Triangle Park, North Carolina', 'institution_ids': ['https://openalex.org/I4210136935', 'https://openalex.org/I4210090916']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5078251319', 'display_name': 'Kevin Laliberte', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210136935', 'display_name': 'United Therapeutics (United States)', 'ror': 'https://ror.org/03wgxjb31', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210136935']}, {'id': 'https://openalex.org/I4210090916', 'display_name': 'Triangle', 'ror': 'https://ror.org/00fhbr831', 'country_code': 'US', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I4210090916']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Kevin Laliberte', 'raw_affiliation_strings': ['United Therapeutics Corp., Research Triangle Park, North Carolina'], 'affiliations': [{'raw_affiliation_string': 'United Therapeutics Corp., Research Triangle Park, North Carolina', 'institution_ids': ['https://openalex.org/I4210136935', 'https://openalex.org/I4210090916']}]}], 'institution_assertions': [], 'countries_distinct_count': 2, 'institutions_distinct_count': 3, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': {'value': 3760, 'currency': 'USD', 'value_usd': 3760, 'provenance': 'doaj'}, 'apc_paid': None, 'fwci': 2.708, 'has_fulltext': True, 'fulltext_origin': 'ngrams', 'cited_by_count': 22, 'citation_normalized_percentile': {'value': 0.800531, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 89, 'max': 90}, 'biblio': {'volume': '50', 'issue': '7', 'first_page': '829', 'last_page': '834'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10728', 'display_name': 'Pulmonary Hypertension Research and Treatments', 'score': 0.9999, 'subfield': {'id': 'https://openalex.org/subfields/2740', 'display_name': 'Pulmonary and Respiratory Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10728', 'display_name': 'Pulmonary Hypertension Research and Treatments', 'score': 0.9999, 'subfield': {'id': 'https://openalex.org/subfields/2740', 'display_name': 'Pulmonary and Respiratory Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11839', 'display_name': 'Hormonal Regulation and Hypertension', 'score': 0.9875, 'subfield': {'id': 'https://openalex.org/subfields/2712', 'display_name': 'Endocrinology, Diabetes and Metabolism'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10198', 'display_name': 'Heart Failure Treatment and Management', 'score': 0.9847, 'subfield': {'id': 'https://openalex.org/subfields/2705', 'display_name': 'Cardiology and Cardiovascular Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/treprostinil', 'display_name': 'Treprostinil', 'score': 0.9515979}, {'id': 'https://openalex.org/keywords/crossover-study', 'display_name': 'Crossover study', 'score': 0.7060218}], 'concepts': [{'id': 'https://openalex.org/C2781109936', 'wikidata': 'https://www.wikidata.org/wiki/Q419769', 'display_name': 'Bosentan', 'level': 4, 'score': 0.95257294}, {'id': 'https://openalex.org/C2776432619', 'wikidata': 'https://www.wikidata.org/wiki/Q3495231', 'display_name': 'Treprostinil', 'level': 3, 'score': 0.9515979}, {'id': 'https://openalex.org/C87813604', 'wikidata': 'https://www.wikidata.org/wiki/Q1242899', 'display_name': 'Crossover study', 'level': 4, 'score': 0.7060218}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.6563587}, {'id': 'https://openalex.org/C112705442', 'wikidata': 'https://www.wikidata.org/wiki/Q323936', 'display_name': 'Pharmacokinetics', 'level': 2, 'score': 0.64722925}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.49196264}, {'id': 'https://openalex.org/C2777056448', 'wikidata': 'https://www.wikidata.org/wiki/Q285166', 'display_name': 'Oral administration', 'level': 2, 'score': 0.48246768}, {'id': 'https://openalex.org/C97320921', 'wikidata': 'https://www.wikidata.org/wiki/Q718753', 'display_name': 'Drug interaction', 'level': 3, 'score': 0.41782928}, {'id': 'https://openalex.org/C2780930700', 'wikidata': 'https://www.wikidata.org/wiki/Q1128595', 'display_name': 'Pulmonary hypertension', 'level': 2, 'score': 0.3680995}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.34591937}, {'id': 'https://openalex.org/C27081682', 'wikidata': 'https://www.wikidata.org/wiki/Q269829', 'display_name': 'Placebo', 'level': 3, 'score': 0.06588015}, {'id': 'https://openalex.org/C144980905', 'wikidata': 'https://www.wikidata.org/wiki/Q24721308', 'display_name': 'Endothelin receptor', 'level': 3, 'score': 0.05975771}, {'id': 'https://openalex.org/C170493617', 'wikidata': 'https://www.wikidata.org/wiki/Q208467', 'display_name': 'Receptor', 'level': 2, 'score': 0.0}, {'id': 'https://openalex.org/C204787440', 'wikidata': 'https://www.wikidata.org/wiki/Q188504', 'display_name': 'Alternative medicine', 'level': 2, 'score': 0.0}, {'id': 'https://openalex.org/C142724271', 'wikidata': 'https://www.wikidata.org/wiki/Q7208', 'display_name': 'Pathology', 'level': 1, 'score': 0.0}], 'mesh': [{'descriptor_ui': 'D000959', 'descriptor_name': 'Antihypertensive Agents', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': True}, {'descriptor_ui': 'D000959', 'descriptor_name': 'Antihypertensive Agents', 'qualifier_ui': 'Q000493', 'qualifier_name': 'pharmacokinetics', 'is_major_topic': True}, {'descriptor_ui': 'D011464', 'descriptor_name': 'Epoprostenol', 'qualifier_ui': 'Q000031', 'qualifier_name': 'analogs & derivatives', 'is_major_topic': True}, {'descriptor_ui': 'D013449', 'descriptor_name': 'Sulfonamides', 'qualifier_ui': 'Q000493', 'qualifier_name': 'pharmacokinetics', 'is_major_topic': True}, {'descriptor_ui': 'D013449', 'descriptor_name': 'Sulfonamides', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': True}, {'descriptor_ui': 'D000293', 'descriptor_name': 'Adolescent', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000328', 'descriptor_name': 'Adult', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000959', 'descriptor_name': 'Antihypertensive Agents', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D000959', 'descriptor_name': 'Antihypertensive Agents', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D019540', 'descriptor_name': 'Area Under Curve', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000077300', 'descriptor_name': 'Bosentan', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D002851', 'descriptor_name': 'Chromatography, High Pressure Liquid', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D018592', 'descriptor_name': 'Cross-Over Studies', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004347', 'descriptor_name': 'Drug Interactions', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D011464', 'descriptor_name': 'Epoprostenol', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D011464', 'descriptor_name': 'Epoprostenol', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D011464', 'descriptor_name': 'Epoprostenol', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': False}, {'descriptor_ui': 'D011464', 'descriptor_name': 'Epoprostenol', 'qualifier_ui': 'Q000493', 'qualifier_name': 'pharmacokinetics', 'is_major_topic': False}, {'descriptor_ui': 'D005260', 'descriptor_name': 'Female', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006207', 'descriptor_name': 'Half-Life', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008297', 'descriptor_name': 'Male', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008875', 'descriptor_name': 'Middle Aged', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D013449', 'descriptor_name': 'Sulfonamides', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D013449', 'descriptor_name': 'Sulfonamides', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D053719', 'descriptor_name': 'Tandem Mass Spectrometry', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D055815', 'descriptor_name': 'Young Adult', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 2, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1177/0091270009351173', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S146237847', 'display_name': 'The Journal of Clinical Pharmacology', 'issn_l': '0091-2700', 'issn': ['0091-2700', '1552-4604'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320595', 'host_organization_name': 'Wiley', 'host_organization_lineage': ['https://openalex.org/P4310320595'], 'host_organization_lineage_names': ['Wiley'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/20133511', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'display_name': 'Good health and well-being', 'score': 0.84, 'id': 'https://metadata.un.org/sdg/3'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 10, 'referenced_works': ['https://openalex.org/W1840736932', 'https://openalex.org/W1974227996', 'https://openalex.org/W2034836771', 'https://openalex.org/W2048443661', 'https://openalex.org/W2088150931', 'https://openalex.org/W2090659780', 'https://openalex.org/W2114017226', 'https://openalex.org/W2314882426', 'https://openalex.org/W2614800967', 'https://openalex.org/W2988610037'], 'related_works': ['https://openalex.org/W4253406936', 'https://openalex.org/W2914992031', 'https://openalex.org/W2469613225', 'https://openalex.org/W2417172109', 'https://openalex.org/W2184784963', 'https://openalex.org/W2168080476', 'https://openalex.org/W2143752321', 'https://openalex.org/W2034734056', 'https://openalex.org/W1997313140', 'https://openalex.org/W1996291418'], 'abstract_inverted_index': {'Treprostinil': [0, 18, 110], 'diethanolamine': [1], 'is': [2, 19, 33], 'an': [3], 'oral': [4, 36, 65, 86, 98, 178], 'prostacyclin': [5], 'analog': [6], 'currently': [7], 'being': [8], 'evaluated': [9, 58], 'for': [10, 44, 119, 189], 'the': [11, 45, 162, 169], 'treatment': [12, 46], 'of': [13, 47, 172, 177], 'pulmonary': [14], 'arterial': [15], 'hypertension': [16], '(PAH).': [17], 'metabolized': [20], 'primarily': [21], 'by': [22], 'cytochrome': [23], 'P450': [24], '(CYP)': [25], '2C8': [26], 'with': [27, 41], 'minor': [28], 'contribution': [29], 'from': [30], 'CYP2C9.': [31], 'It': [32], 'expected': [34], 'that': [35], 'treprostinil': [37, 87, 99, 179], 'will': [38], 'be': [39], 'administered': [40], 'bosentan,': [42, 67], 'approved': [43], 'PAH': [48], 'and': [49, 54, 68, 97, 104, 122, 129, 142, 147, 155, 164, 180], 'known': [50], 'to': [51, 85, 174], 'induce': [52], 'CYP2C9': [53], '3A4.': [55], 'This': [56], 'study': [57, 84], 'whether': [59], 'a': [60, 81, 186], 'drug': [61], 'interaction': [62, 188], 'exists': [63], 'between': [64], 'treprostinil,': [66], 'its': [69], 'active': [70], 'metabolite': [71], 'Ro': [72, 148], '48-5033': [73, 149], 'during': [74], 'co-administration.': [75], 'Twenty-four': [76], 'participants': [77], 'were': [78, 125, 138, 151], 'randomized': [79], 'in': [80, 185], '3-way': [82], 'crossover': [83], '1': [88, 100], 'mg': [89, 94, 101, 107], 'twice': [90, 95, 102, 108], 'daily,': [91, 96], 'bosentan': [92, 105, 135, 181], '125': [93, 106], 'daily': [103], 'daily.': [109], 'geometric': [111], 'mean': [112], 'ratios': [113], '(GMRs)': [114], '(90%': [115], 'confidence': [116], 'interval': [117, 171], '[CIs])': [118], 'steady-state': [120], 'AUC(0-12)': [121], 'C(max)': [123], '(combination/treprostinil)': [124], '0.92': [126], '(0.83,': [127, 131], '1.03)': [128], '0.96': [130], '1.11),': [132], 'respectively,': [133, 146], 'whereas': [134], 'GMRs': [136, 150], '(combination/bosentan)': [137], '1.02': [139], '(0.95,': [140], '1.10)': [141], '1.04': [143], '(0.94,': [144, 157], '1.15),': [145], '0.99': [152], '(0.93,': [153], '1.06)': [154], '1.03': [156], '1.13).': [158], 'In': [159], 'conclusion,': [160], 'because': [161], 'GMR': [163], '90%': [165], 'CI': [166], 'are': [167], 'within': [168], 'equivalence': [170], '0.8': [173], '1.25,': [175], 'co-administration': [176], 'did': [182], 'not': [183], 'result': [184], 'pharmacokinetic': [187], 'either': [190], 'agent.': [191]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W1997313140', 'counts_by_year': [{'year': 2021, 'cited_by_count': 2}, {'year': 2020, 'cited_by_count': 1}, {'year': 2017, 'cited_by_count': 1}, {'year': 2016, 'cited_by_count': 4}, {'year': 2014, 'cited_by_count': 3}, {'year': 2013, 'cited_by_count': 4}, {'year': 2012, 'cited_by_count': 6}], 'updated_date': '2024-12-17T14:16:12.364505', 'created_date': '2016-06-24'}